Extrait

This study will examine the safety, tolerability, and body weight effect of subcutaneous pramlintide alone and in various combinations with the oral antiobesity agents sibutramine or phentermine in overweight and obese subjects.

Critère d'inclusion

• Overweight ,obesity

Liens

• nct
• ictrp